Skip to content
Get alerts
GovInfoNow
Unrated Drug recall · FDA · Published January 11, 2024

Amerisource Health Rifampin Capsules Recall: Failed Impurities Risk

Amerisource Health recalls Rifampin Capsules USP 150mg due to failed impurities/degradation. Rx-only medication with specific NDC numbers and expiration date. Consumers should contact pharmacy for details.

Plain-English summary generated from official FDA data by GovInfoNow · Published by Carlos Caban · How we make summaries

🇺🇸 FDA recall #D-0285-2024DrugAmerisource Health ›
Take action

Contact the company

Recalling firmAmerisource Health Services LLC2550 John Glenn Ave Ste A · Columbus, OH 43217-1188
✎ GovInfoNow plain-language explainer

Amerisource Health is recalling Rifampin Capsules USP 150mg (30 capsules per carton) because of failed impurities or degradation. This could pose a risk to patients taking the medication as prescribed. Read more at govinfonow.com/recall/32885-amerisource-health-rifampin-capsules-recall-failed-impurities-risk.

Source Summary by GovInfoNow · govinfonow.com/recall/32885-amerisource-health-rifampin-capsules-recall-failed-impurities-risk · Updated August 17, 2026 · FDA enforcement record: FDA #D-0285-2024

Cite this page

“Amerisource Health Rifampin Capsules Recall: Failed Impurities Risk.” GovInfoNow, updated August 17, 2026. https://govinfonow.com/recall/32885-amerisource-health-rifampin-capsules-recall-failed-impurities-risk. Based on FDA recall #D-0285-2024 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0285-2024%22&limit=1).

The FDA announced on Jan. 11, 2024, that Amerisource Health Services LLC voluntarily recalled Rifampin Capsels USP due to failed impurities and degradation specifications. The recall affects 1,568 cartons distributed nationwide.

How to tell if you have it

  • Brand: Amerisource Health
  • Product: Rifampin Capsules USP, 150 mg, 30 Capsules (3 x 10) unit doses per carton
  • NDC Carton: 60687-575-21
  • NDC Unit Dose: 60687-575-11
  • Lot #: 1008111
  • Exp. Date: 01/31/2024

The hazard

The recall is due to failed impurities and degradation specifications for the drug, according to the FDA.

Context

GovInfoNow's records show Amerisource Health Services LLC has 30 other recalls on record since July 27, 2022. Other recent recalls of similar products include Hikma Ramipril Capsules 10mg Recall (Aug. 24, 2026) and Appco Pharma Prazosin Capsules Recall (March 27, 2026).

How to tell if you have this one

Check for NDC Carton: 60687-575-21 or NDC Unit Dose: 60687-575-11. The product was distributed by American Health with an expiration date of 01/31/2024.

  • Brand
    Amerisource Health
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Contact Pharmacy

    Talk to your pharmacy about the recall and get guidance on next steps.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Nationwide in the USA” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA terminated this recall 9 months after the firm started it.

1. Firm started the recall: Jan 11, 202412. FDA classified it Class II: Jan 30, 202423. Published in FDA’s Enforcement Report: Feb 7, 202434. FDA terminated the recall: Sep 30, 202442024
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

American Health Packaging Recalls Metoclopramide Tablets Due to Foreign Drug Presence
American Health PackagingTeva Recalls Metoclopramide Tablets Due to Foreign Contaminants
Teva Pharmaceuticals USA, IncPreferred Pharma Recalls Lidocaine Ointment Due to Content Issues
Preferred Pharmaceuticals, Inc.Northstar Rx Recalls Tretinoin Cream Due to Impurities
SUN PHARMACEUTICAL INDUSTRIES INCApothecary Pharma Recalls Tirzepatide Injections Due to Sterility Risk
Apothecary Pharma LLC

Other Amerisource Health recalls

Amerisource Health Services LLC recalls Primidone Tablets, USP, 50 mg, 100 Tablets (10 x 10 unit dose blister) per carton, Rx only, Distributed by: American
May 1, 2026Amerisource Health Services LLC recalls Meclizine Hydrochloride Tablets, USP 12.5 mg, (a) 50 Tablets [5 x 10] (NDC 60687-775-65) (b) 12.5 mg Individual Dose (
March 16, 2026Amerisource Health Services LLC recalls Oxycodone Hydrochloride Tablets, USP (CII), 5 mg, 100-Count (10 x 10) blister cards per carton, Rx Only, The drug
January 14, 2026Amerisource Health Services LLC recalls Potassium Chloride Extended-Release Capsules, USP, (750 mg) 10 mEq K, a).100-count bottle ( NDC 68001-396-00), b)
June 25, 2024

Latest drug recalls

Apotex Corp. recalls Paroxetine Extended-Release Tablets, 37.5mg, 30-count bottle, Rx only, Manufactured by: Apotex Inc., Toronto, Ontario,
Apotex · September 23, 2026Cipla USA, Inc. recalls Fosfomycin Tromethamine Granules for Oral Solution, (Equivalent to 3 Grams of Fosfomycin), 1 Single-Dose Sachet, Rx
Cipla USA · September 18, 2026

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0285-2024 (January 11, 2024) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0285-2024 to see it in context.
  • Plain-language summary written by qwen3:4b on August 17, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA